5-HT1B autoreceptors regulate serotonin release from terminals of dorsal raphe nucleus (DRN) projections. Due to postsynaptic 5-HT1B receptors in DRN terminal fields, it has not previously been possible to manipulate 5-HT1B autoreceptor activity without also changing 5HT(1B) heteroreceptor activity. We have developed a viral gene transfer strategy to express epitope-tagged 5-HT1B and green fluorescent protein in vivo, allowing us to increase 5-HT1B expression in DRN neurons. We have shown that increased 5-HT1B autoreceptor expression reduced anxiety in unstressed animals but increased anxiety following inescapable stress. These findings suggest that effects of increased 5HT(1B) autoreceptor expression are dependent on stress context. To better understand the mechanisms underlying these observations, we have used fear-potentiated startle (FPS). FPS is especially sensitive to the activity of the amygdala, which shares reciprocal connections with DRN. In the absence of an inescapable stressor, increased 5-HT1B autoreceptor expression attenuated FPS response compared with animals injected with a virus expressing only green fluorescent protein. Administration of the 5-HT1B antagonist SB224289 (5 mg/kg i.p.) before startle testing blocked the effects of increased 5-HT1B autoreceptor expression. Since SB224289 had no effect on FPS in the absence of viral gene transfer, these results suggest that the antagonist reversed the behavioral effects of increased 5-HT1B autoreceptor expression through blockade of transgenic receptors. When tested 24 h following water-restraint stress, animals with increased 5-HT1B autoreceptors demonstrated restoration of robust FPS response. These results extend our previous studies and suggest explanations for the complex relationship between 5-HT1B autoreceptor expression, stress, and anxiety behavior. (C) 2004 Elsevier B.V. All rights reserved.